Efficacy and safety of interleukin-17 antagonists in patients with plaque psoriasis: a meta-analysis from phase 3 randomized controlled trials.
about
Efficacy and safety of interleukin-17 antagonists in patients with plaque psoriasis: a meta-analysis from phase 3 randomized controlled trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Efficacy and safety of interle ...... randomized controlled trials.
@en
Efficacy and safety of interle ...... randomized controlled trials.
@nl
type
label
Efficacy and safety of interle ...... randomized controlled trials.
@en
Efficacy and safety of interle ...... randomized controlled trials.
@nl
prefLabel
Efficacy and safety of interle ...... randomized controlled trials.
@en
Efficacy and safety of interle ...... randomized controlled trials.
@nl
P2093
P2860
P356
P1476
Efficacy and safety of interle ...... randomized controlled trials.
@en
P2093
P2860
P304
P356
10.1111/JDV.14125
P577
2017-01-20T00:00:00Z